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Could Value-Based Purchasing Approach Be Used in 
Assessment of Healthcare Delivery Outputs? 
ABSTRACT 
In spite of increasing expenditures for health services, the lack of improvement in 
the quality and patient safety at the desired level brought about the search for reform 
of the reimbursement mechanisms. The main purpose of the present review is a 
search for a comprehensive answer for the question of “Can Value-based 
Purchasing (VPB) approach emerged as such kind of quest and applications 
developed in this context be used to evaluate the outputs of health service 
delivery?”. According to the studies, the VBP approach and especially Hospital 
Value-based Purchasing Program and Hospital-Acquired Conditions Program which 
are the two applications developed under this approach can provide effective results 
in evaluating the outputs in health services and improving quality and patient safety. 
The data show that the VBP approach in health care has the potential to contribute 
significantly to improving the quality and patient safety level of the health care 
service and to keep costs under control. In this context, Hospital Value-based 
Purchasing and Hospital-Acquired Conditions Programs draw attention in terms of 
its potential to be implemented especially in the public sphere in our country. The 
realization of the research and applications in our country aimed at revealing the 
potential benefits of the mentioned programs will facilitate the evaluation. 












Sağlık Hizmet Sunumunun Çıktılarını Değerlendirmede 
Değer Bazlı Satın Alma Yaklaşımı Kullanılabilir mi?  
ÖZET  
Sağlık hizmetleri için yapılan harcamaların giderek artmasına rağmen, buna paralel 
olarak kalite ve hasta güvenliğinin istenen düzeyde gelişmemesi, geri ödeme 
mekanizmalarında reform arayışlarını beraberinde getirmiştir. Bu derlemenin temel 
amacı, “Bu tür arayışların sonucu olarak ortaya çıkan Değer Bazlı Satın Alma 
Yaklaşımı (DBSA) ve bu bağlamda geliştirilen uygulamalar, sağlık hizmet 
sunumunun çıktılarını (output) değerlendirmede kullanılabilir mi?” sorusuna 
kapsamlı bir cevap arayışıdır. Çalışmalara göre DBSA yaklaşımı ve bu yaklaşım 
kapsamında gelişen iki uygulama olan Hastane Değer Bazlı Satın Alma Programı 
ile Hastane Kaynaklı Durumlar Programı, sağlık hizmetlerinde sonuçların 
değerlendirilmesi ve kalite ve hasta güvenliğinin geliştirilmesinde etkili sonuçlar 
ortaya koyabilmektedir. Veriler, sağlık hizmetlerinde DBSA yaklaşımının, alınan 
sağlık hizmetinin kalite ve hasta güvenliği seviyesinin geliştirilerek maliyetlerin 
kontrol altında tutulmasına önemli düzeyde katkı sağlama potansiyeli barındırdığını 
göstermektedir. Bu kapsamdaki Hastane Değer Bazlı Satın Alma ve Hastane 
Kaynaklı Durumlar Programları ülkemizde, özellikle kamusal alanda uygulanabilme 
potansiyeli açısından dikkat çekmektedir. Söz konusu programların potansiyel 
faydalarını ortaya koymaya yönelik ülkemizde de araştırma ve uygulamaların 
gerçekleşmesi, değerlendirme açısından kolaylık sağlayacaktır. 
Anahtar Kelimeler: Değer, Maliyet, Değer Bazlı Satın Alma, Hastane Kaynaklı 
Durumlar
                                                          
 This study was partially based on the PhD thesis conducted by the first author. 
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INTRODUCTION 
The quality and patient safety level in health 
services did not increase at the same rate as the 
expenditures, in other words, despite the increase in 
expenditures, the quality and patient safety did not 
develop at the desired level. This condition brought 
about the search for reimbursement reform. At this 
point, especially for payer institutions (e.g. Social 
Security Institution; SSI), the main concern is the 
insufficient response to the question “Is there a 
difference between the quality of health care 
provided and the one purchased?”. A number of 
approaches and methods developed to address this 
concern have been applied. The US has been a 
pioneer in using these approaches, and developed 
countries such as the UK and Australia have been 
following procurement initiatives that combine 
quality and cost of health care (1,2).  
The American Institute of Medicine's (IoM) 
groundbreaking report, "To Err is Human," 
estimates that the cost incurred "only for 
preventable adverse events" amounts to $37.6 to 
$50 billion, including indirect costs (3). Even in 
other reports by IoM, it is stated that $750 billion 
per year is wasted due to waste, inefficiencies and 
other issues in health care services (4).  
Apart from the extra costs incurred, quality 
problems experienced in health care services can 
cause significant patient safety violations. It is 
stated that as of 2010, Hospital Acquired 
Conditions  (HACs), which developed during 
hospitalization and which is considered as medical 
error, resulted in around 100.000 deaths as well as 
temporary and permanent disabilities (5). Again, 
John Hopkins University researchers Makary and 
Daniel (6) reported that as of 2013, the third most 
common cause of death in the United States was 
deaths caused by an average of more than 250,000 
medical errors per year; it is even stated that this 
figure could go up to 440,000, which is about one-
sixth of all deaths in the United States (7). 
A number of strategies are used to improve 
the level of quality and patient safety in health care 
services provided (8), but the legal and financial 
strategies which are among them are not given 
enough attention in the context of Turkey. For 
example, in a hospital-based on evidence-based 
medicine, pressure sores should not develop during 
hospitalization. But unfortunately, such incidents 
are experienced and payer institutions pay the 
hospitals at a normal rate for the treatment of these 
cases (9,10). 
On the other hand, inability to obtain 
expected outcomes in return for money spent for 
health care services also worries Turkey (11) as 
well as many developed countries (12). Therefore, 
the purchasing power of SSI, which is the biggest 
buyer of health care services in Turkey, has an 
important potential for reducing the costs while 
improving the safety and quality level of the 
healthcare services provided. 
In this study, where the understanding of 
Value-based Purchasing (VBP), which is an 
important tool in promoting the improvement of 
patient safety and quality level of the health care 
service provided, is examined and the 
transformation realized in the incentive structures is 
dealt with in the historical process. Afterward, 
Hospital Value-based Purchasing Program and 
Hospital-Acquired Conditions Program which are 
the two applications having the highest potential as 
part of VBP understanding within the context of 
Turkey are addressed and possible effects of VBP 
on Health Services Providers (HSP) are discussed 
in the context of Turkey. 
 
1. Historical Process of VBP 
Historically, VBP has evolved in three 
stages: Pay-for-reporting (P4R) Programs, Pay-for 
performance (P4P) Programs and Pay-for-value 
(P4V)/Value-based Purchasing (VBP) Programs 
represent these three stages. Initiatives for VBP 
were launched by the Centers for Medicare and 
Medicaid Services (CMS) in the US in 2003 and 
commercial health insurers followed the CMS by 
developing their own programs. The three stages 
indicated are shown in Figure 1 (13,14): 
Figure 1. Stages of Value-based Payment Programs 
Payments are shaped whether service 
providers report certain types of information (e.g. 
quality measurements) to the paying organization 
under P4R Programs (15). These reports formed the 
basis for the measurements to be developed in the 
next stage and P4P programs started to be 
implemented on information infrastructure 
established in this way (16). P4P programs are 
generally based on the principle that hospitals are 
sensitive to income and reputation issues. P4P, 
which increased both of these variables through the 
improvement of quality, became widespread in the 
Pay-for-reporting (P4R) Programs
Pay-for performance (P4P) Programs 
Pay-for-value (P4V) Programs
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USA due to the successful results and started to be 
applied in many countries. However, over time, 
many elements of the method began to be 
criticized, and it is stated that further research is 
needed for payment reform (17–20). In the VBP 
programs that arise in this context, the incentives 
implemented under P4P are directly related to 
quality and efficiency improvements. In this 
context, it is stated that service providers should 
receive payment in terms of their benefits to 
patients and society, rather than their efforts and 
resources that they used in their service production 
(21). 
2. The Concept of Value-based Purchasing 
The National Quality Strategy of the US 
Department of Health and Human Services has 
conceptualized the ultimate goals that the CMS 
wants to achieve in relation to health care 
purchased for the insured under the title of “The 
Triple Aim” as “better health, better care, and less 
cost”. In short, these three characteristics of care, 
which are defined as improving health, improving 
care and reducing costs, form the basis of the 
concept of value. The “value” concept of the CMS 
has improved outcomes with low-cost for 
individuals and society. VBP is one of the tools 
with the highest transformational potential to 
achieve these three goals (22, 23).  
VBP activities are defined as the organized 
initiatives of the healthcare payer organizations that 
they imply their crucial purchasing power towards 
on the one hand negotiating costs with the service 
providers, but on the other hand maintaining quality 
assurance and continuous improvement of quality 
in healthcare services (10). Paying agencies hold 
service providers responsible for the quality and 
cost of care, and incentives are structured to 
eliminate inappropriate, unnecessary and costly 
maintenance (13, 24). In this respect, payer 
organizations have increasingly tended to reward 
the “value”, which means “health outcomes 
achieved per dollar spent” (17). 
In this context, value is based on results, not 
inputs. In other words, value is measured by the 
results achieved, not by the volume of service 
provided (17). A volume-based incentive model 
provides financial incentives to deliver more (and 
more costly) services; however, it typically does not 
provide incentives to improve the quality or 
efficiency of the service provided or to provide 
services with low-profit margins, such as 
preventive services and patient education (25). 
Conversely, in value-based reimbursement, 
there is a reward in return for quality health care 
services, which has been proven to contribute to the 
preservation of health status, reduce errors and 
prevent unnecessary service (26). Therefore, 
incentives are directed towards volume-to-value 
(27), and a significant number of leaders in the field 
of health care services state that the health industry 
is in a transformation from volume to value (9). 
The most critical aspect of VBP 
understanding is standardized, comparative and 
publicly available information on patient outcomes 
related to the health care service provided, the state 
of the health care service, patient experience 
(satisfaction), and direct or indirect costs (13,24). 
On the other hand, in order for VBP initiatives to be 
effective, meaningful criteria and financial rewards 
and penalties that may affect the behaviors of 
service providers should be used (28). 
The transition from pay-per-service to VBP 
in the US is expected to have significant 
implications. For example, only in terms of 
financial savings, it is predicted that the VBP 
payment reform will reduce Medicare expenditures 
by around 214 billion dollars by 2023 (14). 
 
3. Value Based Purchasing Applications 
There are many programs that can be 
associated with the concept of VBP. Two of them 
having quite a high potential in the context of 
Turkey will be covered in this study. These are 
Hospital Value-based Purchasing (HVBP) Program 
and the Hospital-Acquired Conditions (HAC) 
Program: 
3.1.  Hospital Value-based Purchasing Program 
It was mentioned earlier that VBP is a developing 
concept within the scope of P4P applications. P4P, 
on the other hand, is a program of voluntary 
participation of hospitals by origin. However, the 
HVBP Program introduced by the 2010 Affordable 
Care Act is a requirement for all hospitals in the 
US. As part of the program, Medicare began to pay 
hospitals based on clinical processes and patient 
experience measurements. (18).  
The main objectives of the CMS HVBP program 
are as follows: (29):  
• Improving the quality of clinical service, 
• Reducing preventable adverse events and 
improving patient safety, 
• Promoting patient-centered treatment, 
• Avoiding unnecessary costs in service 
delivery. 
HVBP program is a quite complex system (30). 
The program is funded with a deduction to be 
applied to reimbursements made on the basis of 
Diagnosis Related Groups (DRG) in return for the 
services they provide to hospitals. The deduction 
rate was initially defined as 1% and then increased 
by 0.25% each year to 2% for 2017 and beyond. 
This fund, which was established as a neutral 
budget system, is redistributed to hospitals in line 
with the total performance scores of the hospitals. 
Depending on the performance scores obtained, it is 
likely that hospitals will receive less, all or more of 
the outages (18,30,31).  
Domains and the weight of domains that 
constitute the basis of the total performance score to 
be used in the payments to be made to hospitals by 
the beginning of 2013 are given in Table 1 (30,31). 
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Table 1.  Domains and Their Weighting in Total Performance Score 
Domain FY 2013 FY 2014 FY 2015 FY 2016 FY 2017 
Patient Experience of Care 30% 30% 30% 25% 25% 
Clinical Processes of Care 70% 45% 20% 10%  
Outcomes  25% 30% 40%  
Efficiency   20% 25% 25% 





3.2.  Hospital Acquired Conditions Program 
Adverse events that are considered to be 
preventable within the framework of evidence-
based practices within the scope of VBP 
implementations are characterized by the concept of 
non-payment for preventable adverse events. 
As a concept, the first integration study of 
the nonpayment for preventable events approach 
with the reimbursement system was initiated as of 
October 1, 2007, with the requirement to register if 
10 designated HACs were present during the 
patient's hospitalization.  
It was declared to related parties that the 
payment wouldn't be made for discharges as of 
November 1, 2008, in which aforementioned 10 
HACs developed after hospitalization. Because 
Medicare considers HACs to be “preventable 
medical errors and refuses to pay hospitals for these 
conditions, which are also closely related to the 
increase in hospital stay, hospital costs, and patient 
mortality as part of an effort to become a more 
active buyer of health care (32–35). 
In order to include an adverse event in HAC 
as nonpayment for a preventable adverse event, it 
must meet the following three conditions (35):  
• Considered to be high cost or high volume or 
both, 
• To be included in the MS-DRG (Medicare 
Severity-Diagnosis Related Group), which 
requires higher payment when presented as a 
secondary diagnosis. 
• To be reasonably preventable using evidence-
based guidelines. 
The mentioned 10 HACs were increased to 
14 as of 2013 and no changes were made after this 
date. These 14 HACs are listed in Table 2 (36).  
The estimated costs of these HACs 




Table 1. Hospital Acquired Conditions Accepted by CMS 
CMS Hospital Acquired Conditions Accepted 
1. Foreign Object Retained After Surgery  
2. Air Embolism 
3. Blood Incompatibility 
4. Stage III and IV Pressure Ulcers 
5. Falls and Trauma (Fractures, Dislocations, Intracranial Injuries, Crushing Injuries, Burn, Other Injuries) 
6. Manifestations of Poor Glycemic Control (Diabetic Ketoacidosis, Nonketotic Hyperosmolar Coma, 
Hypoglycemic Coma, Secondary Diabetes with Ketoacidosis, Secondary Diabetes with Hyperosmolarity) 
7. Catheter-Associated Urinary Tract Infection (UTI) 
8. Vascular Catheter Associated Infection 
9. Surgical Site Infection, Mediastinitis, Following Coronary Artery Bypass Graft (CABG)  
10. Surgical Site Infection Following Bariatric Surgery for Obesity (Laparoscopic Gastric Bypass, 
Gastroenterostomy, Laparoscopic Gastric Restrictive Surgery) 
11. Surgical Site Infection Following Certain Orthopedic Procedures (Spine, Neck, Shoulder, Elbow) 
12. Surgical Site Infection Following Cardiac Implantable Electronic Device (CIED) 
13. Deep Vein Thrombosis (DVT)/Pulmonary Embolism (PE) Following Total Knee/Hip Replacement 
14. Iatrogenic Pneumothorax with Venous Catheterization 
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Foreign Object Retained After Surgery 750 63.631  47.723.250 
Air Embolism 57 71.636 4.083.252 
Blood Incompatibility 24 50.455 1.210.920 
Stage III and IV Pressure Ulcers 257.412 43.180 11.115.050.160 
Falls and Trauma 193.566 33.894 6.560.726.004 
Manifestations of Poor Glycemic Control 
 Diabetic Ketoacidosis 11.469 42.974 492.868.806 
 Nonketotic Hyperosmolar Coma 32.248 35.215 1.135.613.320 
 Diabetic Coma 1.131 45.989 52.013.559 
 Hypoglycemic Coma 212 36.581 7.755.172 
Catheter-Associated Urinary Tract Infection (UTI) 12.185 44.043 536.663.955 
Vascular Catheter Associated Infection 29.536 103.027 3.043.005.472 
Surgical Site Infections 
 Surgical Site Infection, Mediastinitis, Following Coronary 
Artery Bypass Graft (CABG) 
69 299.237 20.647.353 
 Laparoscopic Gastric Bypass a Gastroenterostomy 208 180.142 37.469.536 
Deep Vein Thrombosis 140.010 50.937 7.131.689.370 
 
There are very few studies on the subject in 
Turkish literature. This study was among them 
dealing with the effects of these HACs. In that 
research carried out in a public educational research 
hospital, HACs, which were found to develop in 
inpatients, could be associated with ₺41.5 million 
additional costs, 46,119 additional hospitalization 
days and 777 additional mortality, annually (39). 
 
4. Considerations in Value-based Purchasing 
Initiatives 
Key aspects of the successful and 
widespread implementation of VBP can be 
expressed as; the adoption of useful and practical 
quality measures, meaningful performance metrics 
that encourages service providers rather than to be a 
burden to them, risk adjustment, preventing the 
occurrence of additional health inequalities to the 
extent possible while reducing the existing ones, 
and providing high-value incentives that encourage 
participation and drive development (13). 
In order to determine the measures to be 
adopted in the context of VBP, the methods used in 
disease cost studies can be utilized, especially in 
relation to the economic consequences of HACs 
developed. For example, the emphasis of 
“determination of perspective” made in such studies 
(40) is important for determining the value of health 
care services for various stakeholders and 
constructing the hierarchy of priorities. 
It is crucial to share data from VBP programs with 
the public and to educate consumers to encourage 
transparency and informed decision-making. In 
addition, as deductions are allocated to high-
performing hospitals, poorly performing service 
providers should focus on preparing action plans to 
correct their shortcomings in order to protect and 
improve their income (13). 
On the other hand, patients' trust in health 
care personnel and the system will be impaired if 
service providers make an effort to obtain specific 
metrics for which outcome measures are valid, 
rather than providing comprehensive care for their 
patients (4). Therefore, first of all, utmost 
importance should be given physicians and all the 
staff operating in the system to adopt a value-based 
system (16). In addition, as incentive structures can 
change over time in line with the progress made 
under such programs, hospitals should develop their 
ability to be flexible and adapt to these changes. In 
this case, the risk of regression is always present in 
the performance areas which are no longer subject 
to reimbursement and necessary precautions should 
be taken against this risk. 
 
CONCLUSION 
The Hospital Value-based Purchasing 
Program and the Hospital-Acquired Conditions 
Program are particularly noteworthy in terms of its 
potential to be implemented in the public sphere in 
our country. The VBP program has a significant 
potential for the formulation of policies that can be 
implemented by the SSI. In order to be covered the 
funding source of VBP programs from deductions 
made from payments based on Diagnosis Related 
Groups (DRGs), firstly payment based on DRG 
should be constructed in Turkey. And for this, IT 
infrastructure should be established as soon as 
possible. In conclusion, the VBP approach is a tool 
that has significant potential in improving quality 
and patient safety in health care services and 
keeping costs under control. 
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